Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bioventus Inc. BVS

Set alert

Price alert · BVS

All alert types
13.15 USD -0.17 -1.31%

At close · Nov 2

10.96 -2.19 -16.65%

After hours · Nov 2, 6:57 PM ET

Bid
13.12 × 2
Ask
13.13 × 2
13.07 Day range 13.73
6.47 52-week range 15.89
YTD
+76.75%
1 year
+100.76%
Open
13.52
Prev close
13.33
Mkt cap
898.21M
Vol
681.38K
Avg vol
562.45K
EPS
0.78
P/E
16.86
Div yield
0.00%
More statistics
Low
13.07
High
13.73
Forward P/E
16.16
Beta
0.64
Short ratio
7.53
Inst. own
84.85%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
13.72
200-d avg
10.84
1y target
17.60

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 6, 2026Earnings: 0.15; estimate 0.09; surprise 66.67%
  • May 22, 2026Rating: Barrington Research · Outperform → Outperform
  • Jun 16, 2026Rating: Canaccord Genuity · Buy → Buy
  • Jun 30, 2026Rating: Barrington Research · Outperform → Outperform
  • Aug 5, 2026Earnings: 0.22; estimate 0.2163; surprise 1.71%
  • Aug 17, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
  • Aug 17, 2026Rating: Canaccord Genuity · Buy → Buy
  • Nov 2, 2026Earnings: —; estimate 0.1496; surprise —%
Signals (34)
NameDateAgo
MACD: Sell SignalNov 2, 202612 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
MACD: Buy SignalOct 14, 20262 weeks ago
MACD: Sell SignalOct 2, 20261 month ago
SMA: BearishOct 1, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalAug 12, 20262 months ago
RSI: OverboughtAug 5, 20262 months ago
RSI: OverboughtAug 3, 20263 months ago
MACD: Buy SignalJul 28, 20263 months ago
MACD: Sell SignalJul 22, 20263 months ago
RSI: OverboughtJul 13, 20263 months ago
RSI: OverboughtJul 6, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
SMA: BullishJun 25, 20264 months ago
SMA: BullishJun 23, 20264 months ago
MACD: Buy SignalJun 16, 20264 months ago
MACD: Sell SignalJun 12, 20264 months ago
SMA: BearishJun 10, 20264 months ago
MACD: Buy SignalJun 10, 20264 months ago
SMA: BullishJun 9, 20264 months ago
RSI: OversoldJun 1, 20265 months ago
SMA: BearishMay 27, 20265 months ago
SMA: BearishMay 21, 20265 months ago
MACD: Sell SignalMay 21, 20265 months ago
MACD: Buy SignalMay 20, 20265 months ago
MACD: Sell SignalMay 12, 20265 months ago
MACD: Buy SignalMay 5, 20266 months ago

Financial health

Altman Z-Score

2.14 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 2

Valuation

P/E 21.9×
FY 2016: -46.9×FY 2017: -148×FY 2018: -87.3×FY 2019: 160×FY 2020: 43.7×FY 2021: 33.7×FY 2022: -1.0×FY 2023: -2.1×FY 2024: -20.2×FY 2025: 21.9×
FY 2016 5y median -1.0× FY 2025
P/S 0.9×
FY 2016: 4.0×FY 2017: 3.7×FY 2018: 3.4×FY 2019: 3.2×FY 2020: 2.3×FY 2021: 1.5×FY 2022: 0.3×FY 2023: 0.6×FY 2024: 1.2×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/B 2.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 7.5×FY 2019: 0.0×FY 2020: 5.1×FY 2021: 1.4×FY 2022: 0.5×FY 2023: 1.9×FY 2024: 4.6×FY 2025: 2.7×
FY 2016 5y median 1.9× FY 2025
P/FCF 6.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 27.9×FY 2019: 0.0×FY 2020: 14.2×FY 2021: 314×FY 2022: -10.7×FY 2023: 41.4×FY 2024: 18.2×FY 2025: 6.9×
FY 2016 5y median 18.2× FY 2025
EV/EBITDA 7.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 22.8×FY 2019: 0.0×FY 2020: 15.2×FY 2021: 21.4×FY 2022: -4.5×FY 2023: -29.8×FY 2024: 25.0×FY 2025: 7.6×
FY 2016 5y median 7.6× FY 2025
EV/Sales 1.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 3.9×FY 2019: 0.0×FY 2020: 2.6×FY 2021: 2.3×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 1.7×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
FCF Yield 14.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 3.6%FY 2019: 0.0%FY 2020: 7.1%FY 2021: 0.3%FY 2022: -9.4%FY 2023: 2.4%FY 2024: 5.5%FY 2025: 14.4%
FY 2016 5y median 2.4% FY 2025

Profitability

Gross Margin 67.3%
FY 2016: 66.7%FY 2017: 68.5%FY 2018: 73.6%FY 2019: 73.3%FY 2020: 72.7%FY 2021: 70.3%FY 2022: 64.6%FY 2023: 64.1%FY 2024: 67.7%FY 2025: 67.3%
FY 2016 5y median 67.3% FY 2025
Operating Margin 10.3%
FY 2016: 5.4%FY 2017: 9.3%FY 2018: 8.0%FY 2019: 9.2%FY 2020: 6.6%FY 2021: 2.8%FY 2022: -32.7%FY 2023: -16.0%FY 2024: -2.1%FY 2025: 10.3%
FY 2016 5y median -2.1% FY 2025
Net Margin 4.0%
FY 2016: -6.5%FY 2017: -0.6%FY 2018: -3.8%FY 2019: 2.0%FY 2020: 5.1%FY 2021: 4.5%FY 2022: -31.0%FY 2023: -30.5%FY 2024: -5.9%FY 2025: 4.0%
FY 2016 5y median -5.9% FY 2025
ROE 12.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -8.4%FY 2019: 0.0%FY 2020: 11.5%FY 2021: 4.2%FY 2022: -48.8%FY 2023: -90.0%FY 2024: -22.7%FY 2025: 12.3%
FY 2016 5y median -22.7% FY 2025
ROIC 10.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 4.9%FY 2019: 0.0%FY 2020: 5.1%FY 2021: 1.1%FY 2022: -11.6%FY 2023: -12.3%FY 2024: -2.0%FY 2025: 10.8%
FY 2016 5y median -2.0% FY 2025
ROA 3.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2.8%FY 2019: 0.0%FY 2020: 3.3%FY 2021: 1.6%FY 2022: -11.6%FY 2023: -19.3%FY 2024: -4.6%FY 2025: 3.3%
FY 2016 5y median -4.6% FY 2025

Growth (YoY)

Revenue -0.9%
FY 2016: 8.2%FY 2017: 6.4%FY 2018: 9.3%FY 2019: 6.6%FY 2020: -5.6%FY 2021: 34.2%FY 2022: 18.8%FY 2023: 0.0%FY 2024: 11.9%FY 2025: -0.9%
FY 2016 FY 2025
Operating Income 588.7%
FY 2016: 189.8%FY 2017: 81.5%FY 2018: -5.6%FY 2019: 22.3%FY 2020: -31.9%FY 2021: -43.2%FY 2022: -1486.6%FY 2023: 51.1%FY 2024: 85.3%FY 2025: 588.7%
FY 2016 FY 2025
EPS (diluted) 163.5%
FY 2016: 40.6%FY 2017: 68.3%FY 2018: -69.2%FY 2019: 154.5%FY 2020: 266.7%FY 2021: -2.3%FY 2022: -702.3%FY 2023: 3.9%FY 2024: 79.1%FY 2025: 163.5%
FY 2016 FY 2025
Free Cash Flow 89.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -95.9%FY 2022: -814.7%FY 2023: 153.2%FY 2024: 373.4%FY 2025: 89.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.3×FY 2019: 0.0×FY 2020: 1.7×FY 2021: 1.5×FY 2022: 0.9×FY 2023: 1.5×FY 2024: 1.3×FY 2025: 1.7×
FY 2016 5y median 1.5× FY 2025
Quick Ratio 1.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 1.8×FY 2019: 0.0×FY 2020: 1.5×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 1.0×FY 2024: 0.9×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 1.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 1.3×FY 2019: 0.0×FY 2020: 1.3×FY 2021: 0.8×FY 2022: 1.3×FY 2023: 2.3×FY 2024: 2.3×FY 2025: 1.7×
FY 2016 5y median 1.7× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.8×FY 2019: 0.0×FY 2020: 1.9×FY 2021: 6.9×FY 2022: -3.2×FY 2023: -15.5×FY 2024: 7.5×FY 2025: 2.6×
FY 2016 5y median 2.6× FY 2025
Interest Coverage 2.2×
FY 2016: 0.9×FY 2017: 1.4×FY 2018: 1.3×FY 2019: 1.4×FY 2020: 2.2×FY 2021: 10.8×FY 2022: -13.9×FY 2023: -2.0×FY 2024: -0.3×FY 2025: 2.2×
FY 2016 5y median -0.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.7%FY 2019: 0.0%FY 2020: 2.7%FY 2021: 0.1%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -64.3%FY 2019: 0.0%FY 2020: 121.2%FY 2021: 1.9%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31